Difference between revisions of "Ber-EP4"

Jump to navigation Jump to search
9 bytes added ,  17:05, 15 May 2016
Line 3: Line 3:
==Positive==
==Positive==
*[[Basal cell carcinoma]].
*[[Basal cell carcinoma]].
*[[Lung adenocarcinoma]] (55 of 59 cases<ref name=pmid9426522>{{Cite journal  | last1 = Ordóñez | first1 = NG. | title = Value of the Ber-EP4 antibody in differentiating epithelial pleural mesothelioma from adenocarcinoma. The M.D. Anderson experience and a critical review of the literature. | journal = Am J Clin Pathol | volume = 109 | issue = 1 | pages = 85-9 | month = Jan | year = 1998 | doi =  | PMID = 9426522 }}</ref>).
*[[Lung adenocarcinoma]] (55 positive of 59 cases<ref name=pmid9426522>{{Cite journal  | last1 = Ordóñez | first1 = NG. | title = Value of the Ber-EP4 antibody in differentiating epithelial pleural mesothelioma from adenocarcinoma. The M.D. Anderson experience and a critical review of the literature. | journal = Am J Clin Pathol | volume = 109 | issue = 1 | pages = 85-9 | month = Jan | year = 1998 | doi =  | PMID = 9426522 }}</ref>).


==Negative==
==Negative==
48,466

edits

Navigation menu